VYNT Insider Trading

Insider Ownership Percentage: 9.56%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Vyant Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Vyant Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vyant Bio Share Price & Price History

Current Price: $0.19
Price Change: Price Increase of +0.014 (7.78%)
As of 12/29/2023 10:03 PM ET

This chart shows the closing price history over time for VYNT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Vyant Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/6/2021Marcus BoehmDirectorBuy5,000$1.69$8,450.00View SEC Filing Icon  
11/24/2021John A. RobertsCEOBuy5,000$2.02$10,100.00View SEC Filing Icon  
11/22/2021Yung-Ping YehInsiderBuy500$2.05$1,025.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vyant Bio (OTCMKTS:VYNT)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VYNT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vyant Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2022Country Club Bank GFN20,000$32K0.0%N/A0.068%Search for SEC Filing on Google Icon
1/28/2022Taylor Wealth Management Partners47,946$65K0.0%-41.7%0.165%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC20,504$77K0.0%-47.7%0.071%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.13,043$49K0.0%N/A0.045%Search for SEC Filing on Google Icon
8/16/2021State Street Corp52,771$0.20M0.0%N/A0.182%Search for SEC Filing on Google Icon
8/16/2021Frontier Wealth Management LLC202,601$0.76M0.1%N/A0.699%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp43,901$0.16M0.0%+124.0%0.151%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC176,680$0.66M0.0%+203.0%0.610%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.839,226$3.14M0.0%+881.6%2.895%Search for SEC Filing on Google Icon
8/12/2021NorthRock Partners LLC18,832$70K0.0%N/A0.065%Search for SEC Filing on Google Icon
8/12/2021Bank of Montreal Can10,000$37K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/11/2021Taylor Wealth Management Partners85,621$0.32M0.1%N/A0.295%Search for SEC Filing on Google Icon
8/10/2021Blankinship & Foster LLC205,094$0.77M0.3%N/A0.708%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC39,211$0.18M0.0%N/A0.356%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC180,926$0.84M0.0%N/A1.644%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.10,000$46K0.0%N/A0.091%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp19,599$91K0.0%N/A0.178%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC58,305$0.27M0.0%N/A0.530%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.164,647$0.76M0.0%N/A1.496%Search for SEC Filing on Google Icon
4/26/2021GWM Advisors LLC56,017$0.26M0.0%N/A0.509%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC20,164$56K0.0%N/A0.494%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC242,801$0.67M0.0%+25.5%5.944%Search for SEC Filing on Google Icon
1/27/2021Country Club Trust Company n.a.20,000$56K0.0%N/A0.490%Search for SEC Filing on Google Icon
11/9/2020Acadian Asset Management LLC18,001$75K0.0%+435.6%0.718%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vyant Bio logo
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.
Read More on Vyant Bio

Today's Range

Now: $0.19
Low: $0.18
High: $0.20

50 Day Range

MA: $0.19
Low: $0.19
High: $0.19

52 Week Range

Now: $0.19
Low: $0.14
High: $1.58

Volume

19,100 shs

Average Volume

161,822 shs

Market Capitalization

$1.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73